###### Key messages

-   In the largest study of respiratory mechanics (by impulse oscillometry) within an obese population to date, we identify an effect of abdominal mass loading on airways resistance. This effect is greatest in the small airways and is expressed differentially between those with and without ventilatory failure.

Introduction {#s1}
============

'Pickwickian' syndrome or obesity hypoventilation syndrome (OHS) is defined as obesity-related chronic ventilatory failure, where ventilatory failure is defined as a daytime hypercapnia with an arterial PaCO~2~ of \>6 kPa.

OHS has been characterised as a 'restrictive' disease; whereby in obesity increased mass requires increased work to move the thoracic wall and abdomen during breathing. The inability to adequately compensate therefore results in hypoventilation and retention of carbon dioxide in OHS.

To some degree, classical spirometry results from obese patients support this hypothesis: these characteristically show a preserved forced expiratory volume in 1 s (FEV1)/forced vital capacity (FVC) ratio,[@R1] with FEV1 not depressed until at the extremes of morbid obesity,[@R4] implying a restrictive pattern. Furthermore, obese patients demonstrate reduced expiratory reserve volume (ERV)[@R5] [@R9] [@R10] and functional residual capacity (FRC) values.[@R5] [@R9] [@R10] However, total lung capacity (TLC)[@R3] [@R5] [@R7] [@R11] and residual volume (RV)[@R4] [@R11] are spared; others have shown that overall airways resistance is increased in obesity, implying an obstructive element in the pathophysiology.[@R12] [@R13] Given that the mechanical properties of the airways, such as resistance, are dependent on lung volume itself, some have attempted to resolve the question by analyses of airways resistance that account for reduced lung volume.[@R14] However, two studies have found that increased resistance persists after this adjustment.[@R6] [@R15] Furthermore, the finding that the frequency dependence of resistance increases with obesity has implicated the small peripheral airways as the site of obesity-related changes.[@R12]

In normal participants, there is a small reduction in FRC and increase in airflow resistance on adopting the supine posture.[@R16] Supine posture is a physiological variable, thought to be due to the gravitational effects of the abdominal contents exerting mass loading, resulting in the relaxed diaphragm taking a more expiratory position; increasing mass when supine should amplify the tendency to lengthen the passive diaphragm.

We have recently published cohort data demonstrating that visceral adipose tissue (VAT) mass is an independent correlate of chronic ventilatory failure,[@R17] and that, within this cohort, obese patients with a raised bicarbonate but no hypercapnia represent an early form of OHS.[@R18]

Here, we further investigate this cohort with the hypothesis that the VAT component within obese patients may specifically mediate respiratory pathophysiology. We use impulse oscillometry (IOS), a forced oscillation technique pioneered by DuBois *et al*,[@R19] which, in contrast to classical spirometry, provides an effort independent measure of lung function. In this technique, forced oscillations are superimposed over a range of frequencies on regular breathing allowing the extraction of certain derivatives to estimate resistance in different parts of the lung. Dual-energy X-ray absorptiometry (DXA) is an established method of evaluating body composition and distributions and has been validated by CT studies.[@R20] [@R21]

Methods {#s2}
=======

Study design and setting {#s2a}
------------------------

An open cross-sectional cohort study of obese patients was undertaken between June 2011 and September 2013 at the Oxford Sleep Unit, Oxford Centre for Respiratory Medicine. The study was registered prospectively with a global trials registry site (ClinicalTrials.gov NCT01380418) and was approved by the Oxford Research Ethics Committee (Oxfordshire REC B 11/H0605/9).

Participants {#s2b}
------------

A convenience sample of obese patients (defined as a body mass index (BMI) of \>30 kg/m^2^), with or without chronic ventilatory failure, was recruited following referral to the sleep and ventilation unit, or during assessment for possible bariatric surgery. Exclusion criteria included: being currently on any drug that might potentially stimulate/depress respiration, a diuretic or a theophylline; being diagnosed with obstructive lung disease (defined as an FEV1/FVC ratio \<70%); or the presence of other severe comorbidities, for example, congestive cardiac failure, primary central nervous system or neuromuscular diseases, and untreated hypothyroidism; or being currently on treatment with continuous positive airways pressure (CPAP) or non- invasive ventilation.

Measures of airways resistance by IOS {#s2c}
-------------------------------------

Seated IOS measurements were taken in line with European Thoracic Society guidelines (ETS) Task Force recommendations,[@R22] using the Jaeger MS-IOS machine (Care Fusion, Germany). Forced oscillation was applied at the airway opening during normal tidal breathing to measure respiratory impedance. The participant supported the cheeks and floor of the mouth with the palms of the hands to minimise dissipation of the applied flow in the upper airway. The head and neck were kept in a neutral to slightly extended position, while the participant maintained tidal breathing via a large-bore mouthpiece and with a nose clip in place. In the supine measurements, participants lay in the standard anatomical supine position, with legs fully extended and arms fully extended supine. A nose clip was worn to avoid shunting via the nose during the measurement, and the cheeks were firmly supported by the experimenter to avoid shunting across the mouth. The participant was asked to breathe normally. Data were excluded if the participant began to swallow, breathe irregularly, hyperventilate or if glottis closure occurred. Furthermore, if there was leakage around the mouthpiece or a fault with the nose clip, or improper support of the cheeks, data were excluded. IOS measurements of overall resistance (R5) and large airways resistance (R20) were recorded, with the R5--R20 calculation used to determine small airways resistance. A Lilly-type pneumotachograph was used for flow measurements, following calibration with a 3 L syringe. Flow was kept to a maximum peak expiratory and peak inspiratory flow of 0.50 L/s (body temperature and pressure, saturated (BTPS)), thus simulating the flow range of spontaneous quiet breathing. Before and after testing, a 90 s impedance measurement was performed using a fixed impedance of 0.2 kPa/s/L to ascertain impulse pressure and flow accuracy.

Measures of adiposity and its distribution {#s2d}
------------------------------------------

In addition to basic anthropometric data (age, sex, height, weight, BMI), body fat and its distribution were assessed by DXA (Lunar system (GE Healthcare, Chalfont St Giles, UK)). DXA measures were of total body fat and trunk fat, with an estimation of VAT mass calculated only available in participants with a BMI≤40, as the algorithm has not been verified beyond this level of obesity.[@R23]

Participant grouping {#s2e}
--------------------

Following arterial blood gas analysis, participants were divided a priori into two 'clinical' groups, representing those with ventilatory failure and those without. Those with a normal daytime PaCO~2~ but elevated base excess were excluded as they may represent an early form of OHS[@R18] and therefore be confounding. Normal daytime PaCO~2~ (≤6 kPa) and base excess \<2 mmol/LElevated daytime PaCO~2~ (\>6 kPa).

Statistical analyses {#s2f}
--------------------

Data analyses were recorded using MS Excel and analysed using SPSS (V.22, IBM Corporation Ltd, USA). Descriptive data are presented as the mean and SD for normally distributed data. Data were tested for normality and parametric analyses conducted when appropriate. Paired t tests were performed to analyse any differences between seated and supine measures of airways resistance generated by the IOS method (R5, R20 and R5--R20). Pearson\'s correlations were performed between measures of adiposity (weight, BMI, DXA total fat, DXA trunk fat and DXA VAT mass) and both seated and supine IOS measures of airways resistance. A series of unpaired t tests were used to test for differences in mean values of airways resistance between our two participant groups.

Results {#s3}
=======

Seventy-two morbidly obese patients (40 males, 32 females) had anthropometric measurements, measures of airways resistance and adiposity as described. Descriptive results for these data-points are presented in [table 1](#BMJRESP2016000138TB1){ref-type="table"}. Mean measures for all components of airways resistance were elevated when compared with previously described values for non-obese patients in the supine position (reference data available in online [supplementary table](#SM1){ref-type="supplementary-material"} S1).

###### 

Descriptive statistics for anthropometric measures, measures of adiposity and IOS measures of airways resistance

                                          n    Minimum   Maximum   Mean    SD
  --------------------------------------- ---- --------- --------- ------- ------
  *(A) Anthropometric measures*                                            
  Age (years)                             72   26        74        52.0    8.8
  Height (cm)                             72   149       188       170.0   9.3
  Weight (kg)                             72   78        229       136.0   29.5
  *(B) Measures of adiposity*                                              
  BMI (kg/m^2^)                           72   32.3      73.9      47.2    9.8
  DXA total fat (kg)                      55   32.3      86.2      58.2    13.5
  DXA trunk fat (kg)                      55   22.0      55.7      35.7    8.0
  DXA visceral adipose tissue mass (kg)   21   1.8       5.2       3.2     1.0

                                             Seated (n=70)   Supine (n=69)   Supine vs Seated                                 
  ------------------------------------------ --------------- --------------- ------------------ -------- ------ ------ ------ ----------
  *(C) IOS measures of airways resistance*                                                                                    
  R5                                         0.18            1.01            0.50               0.10     1.17   0.69   0.19   \<0.0005
  (kPa/L/s)                                  (0.18)          (0.21)          (+37%)                                           
  R20                                        0.13            0.70            0.33               0.10     0.79   0.43   0.10   \<0.0005
  (kPa/L/s)                                  (0.12)          (0.12)          (+29%)                                           
  R5--R20                                    0.00            0.50            0.17               --0.02   0.69   0.26   0.09   \<0.0005
  (kPa/L/s)                                  (0.11)          (0.15)          (+52%)                                           

R5, overall airways resistance; R20, large airways resistance; R5--R20, small airways resistance; BMI, body mass index; DXA, dual-energy X-ray absorptiometry; IOS, impulse oscillometry.

10.1136/bmjresp-2016-000138.supp1

Paired t tests demonstrated that all measures of airways resistance increase significantly when measured in the supine position versus the seated position. Supine R5 values were higher (0.69±0.21 kPa/s/L) than seated values (0.50±0.19 kPa/s/L), a statistically significant increase of 0.19 kPa/s/L (37%) (95% CI 0.14 to 0.23, t(71)=7.994, p\<0.0005, d=0.95). Supine R5-R20 CI 0.06 to 0.12, values were higher (0.43±0.15 kPa/s/L) than seated values (0.33±0.12 kPa/s/L), a statistically significant increase of 0.10 kPa/s/L (29%) (95% CI 0.06 to 0.12, t(70)=7.122, p\<0.0005, d=0.85). Supine R5--R20 values were higher (0.26±0.15 kPa/s/L) than seated values (0.17±0.11 kPa/s/L), a statistically significant increase of 0.09 kPa/s/L (52%) (95% CI 0.61 to 0.12, t(71)=6.310, p\<0.0005, d=0.75).

Pearson\'s correlation coefficients between measures of adiposity and airways resistance, both in the seated and supine positions, are presented in [table 2](#BMJRESP2016000138TB2){ref-type="table"}. Significant p values are marked with an asterisk. BMI was significantly correlated with seated and supine measures of total airways resistance (R5) and small airways resistance (R5--R20), with the strength of this correlation varying between r=0.30 and r=0.36. VAT mass was significantly correlated with a supine measure of small airways resistance, with the strength of this correlation being r=0.46. Since VAT mass could only be validly measured in the subgroup of our cohort with a BMI\<40, descriptive data demonstrating similar characteristics to the overall cohort are presented in online [supplementary table](#SM1){ref-type="supplementary-material"} S2.

###### 

Correlations between measures of adiposity and measures of airways resistance

                                                                             n    Pearson\'s r   p Value
  -------------------------------------------------------------------------- ---- -------------- ---------
  *(A) Measures of adiposity vs seated R5 (total airways resistance)*                            
  Weight (kg)                                                                70   +0.13          0.28
  BMI                                                                        70   +0.33          0.005\*
  DXA total fat (kg)                                                         54   +0.15          0.28
  DXA trunk fat (kg)                                                         54   +0.09          0.51
  DXA visceral adipose tissue mass (kg)                                      21   --0.11         0.62
  *(B) Measures of adiposity vs seated R20 (large airways resistance)*                           
  Weight (kg)                                                                70   --0.01         0.99
  BMI                                                                        70   +0.18          0.13
  DXA total fat (kg)                                                         54   --0.01         0.31
  DXA trunk fat (kg)                                                         54   --0.07         0.48
  DXA visceral adipose tissue mass (kg)                                      21   --0.36         0.11
  *(C) Measures of adiposity vs seated R5--R20 (small airways resistance)*                       
  Weight (kg)                                                                69   +0.22          0.07
  BMI                                                                        69   +0.32          0.003\*
  DXA total fat (kg)                                                         54   +0.27          0.048\*
  DXA trunk fat (kg)                                                         54   +0.24          0.08
  DXA visceral adipose tissue mass (kg)                                      20   --0.17         0.49
  *(D) Measures of adiposity vs supine R5 (total airways resistance)*                            
  Weight (kg)                                                                69   +0.24          0.05
  BMI                                                                        69   +0.30          0.01\*
  DXA total fat (kg)                                                         53   +0.09          0.50
  DXA trunk fat (kg)                                                         53   +0.11          0.43
  DXA visceral adipose tissue mass (kg)                                      21   +0.36          0.11
  *(E) Measures of adiposity vs supine R20 (large airways resistance)*                           
  Weight (kg)                                                                69   +0.13          0.30
  BMI                                                                        69   +0.23          0.06
  DXA total fat (kg)                                                         53   +0.02          0.92
  DXA trunk fat (kg)                                                         53   +0.03          0.98
  DXA visceral adipose tissue mass (kg)                                      21   +0.10          0.67
  *(F) Measures of adiposity vs supine R5--R20 (small airways resistance)*                       
  Weight (kg)                                                                69   ±0.22          0.07
  BMI                                                                        69   ±0.36          0.03\*
  DXA total fat (kg)                                                         53   +0.12          0.39
  DXA trunk fat (kg)                                                         53   +0.16          0.27
  DXA visceral adipose tissue mass (kg)                                      21   +0.46          0.04\*

R5, overall airways resistance; R20, large airways resistance; R5--R20, small airways resistance; BMI, body mass index; DXA, dual-energy X-ray absorptiometry.

Student\'s t tests between our two participant groups are presented in [table 3](#BMJRESP2016000138TB3){ref-type="table"}. Significant p values are marked with an asterisk. Weight, BMI, supine measures of total airways resistance (R5) (as p = 0.050 exactly and is NOT less than 0.05) were statistically different between those with and without ventilatory failure.

###### 

Student\'s t tests of anthropometric and airways measures between participant groups

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                   Non-ventilatory failure group\   Ventilatory failure group\   t-Statistic (df)   Difference between means   Percentage of difference   p Value of t-statistic
                   n=31                             n=15                                                                                                  
  ---------------- -------------------------------- ---------------------------- ------------------ -------------------------- -------------------------- ------------------------
  Age (years)      53.2 (9.5)                       54.6 (8.1)                   0.492 (44)         +1.41                      +2.65                      0.625

  Weight (kg)      130.6 (29.4)                     153.3 (36.8)                 2.256 (44)         +22.7                      +17.3                      0.029\*

  BMI (kg)         45.1 (9.1)                       53.0 (12.3)                  2.201 (21.7)†      +7.9                       +17.5                      0.039\*

  R5 seated        0.50 (0.22)                      0.58 (0.16)                  1.325 (44)         +0.083                     +16.8                      0.192

  R20 Seated       0.33 (0.14)                      0.35 (0.10)                  0.538 (44)         +0.021                     +6.45                      0.593

  R5--R20 seated   0.167 (0.12)                     0.22 (0.12)                  1.645 (44)         +0.062                     +37.6                      0.107

  R5 supine        0.64 (0.20)                      0.79 (0.24)                  2.253 (44)         +0.15                      +23.6                      0.029\*

  R20 supine       0.40 (0.12)                      0.46 (0.10)                  2.016 (44)         +0.070                     +17.7                      0.05

  R5--R20 supine   0.24 (0.13)                      0.32 (0.19)                  1.488 (20.05)†     +0.080                     +33.1                      0.152
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

\*p\<0.05. Data are presented as mean values with SDs in brackets.

†Levene\'s Test for homogeneity of variances violated (p\<0.05), therefore t test not assuming equal variances performed.

R5, overall airways resistance; R20, large airways resistance; R5--R20, small airways resistance; BMI, body mass index.

Discussion {#s4}
==========

This exploratory study provides data on airways resistance in the largest cohort of obese patients studied by IOS until now. That respiratory resistance is increased in the supine posture is in concordance with previously published data,[@R6] [@R14] [@R24] though our results further this knowledge by demonstrating a differential effect by airway calibre: there is a large effect in small airways (52%) with a smaller effect in larger airways (29%), with total airways resistance lying in between these two values (37%).

We also demonstrate a novel correlation between BMI and supine VAT mass with airways resistance. Our previous work[@R17] has demonstrated that VAT mass is the best independent correlate of ventilatory failure, while BMI is a comparatively poor correlate. Taken together, these two results suggest that fat within the abdominal cavity is significant in obesity-related respiratory pathophysiology. This hypothesis is supported with classical spirometry results within the literature: a negative correlation between VAT and FEV1/FVC is documented in the literature. While this correlation was initially discovered in studies using waist circumference as a surrogate marker for VAT mass, the result has also been replicated using more precise techniques: Rossi *et al*[@R25] (CT), Park *et al*[@R26] (CT), Inomata *et al*[@R27] (Bioimpedance) and Thijs *et al*[@R28] (MRI).

Furthermore, a cross-sectional population-based study of nearly 122 000 participants showed that abdominal obesity was the strongest correlate of impaired lung function[@R29] while early work in this area identified a reduced ERV as a possible provoker of obesity-related hypoventilation.[@R30] Sutherland *et al*[@R31] used a wide range of body fat variables (including DXA to determine the effect of fat distribution on lung volumes), to demonstrate that in healthy adults lung volumes were only loosely associated with BMI. BMI is regarded as an unreliable method of evaluating causal associations between obesity and disease, a view based on the finding that the distribution of adipose tissue has been shown to be more predictive in the development of metabolic disorders.[@R29] [@R32]

In a clinical context, this preferential abdominal obesity is a plausible contributory cause to the gradual development of daytime hypercapnia. The effect of a raised intra-abdominal pressure on ventilation is well recognised in individuals with other pathologies that raise intra-abdominal pressure (refer to Hedenstierna and Larsson[@R33] for review). This is particularly seen in acutely ill patients in intensive care, where additional obesity has been shown to be a significant risk factor for ventilatory failure.[@R34]

Additionally, our results provide evidence for small airways as the anatomical location of obesity-related resistive pathophysiology, a conclusion corroborated by the finding that the frequency dependence of resistance increases with obesity.[@R12] A simple explanation for this finding might be that in the supine position the effect of mass loading to the thoracic cavity, and thus lung volume, is amplified. In our study, hypercapnic obese individuals (ie, those meeting the criteria for OHS), had, on average, greater airways resistance in the supine position when compared with obese individuals who were not in ventilatory failure. This result supports the suggestion that supine mass loading may mediate obesity-related respiratory pathophysiology to the extent that it causes disease.

Mass loading may affect respiratory mechanics by other mechanisms such as altering chest wall compliance directly by restricting expansion and causing the respiratory system to operate on a less compliant part of the pressure-volume curve. Interestingly, one study reports the compliances of the thorax and total respiratory system in obese patients as low as 20% of normal.[@R35] Alternatively, mass loading preventing descent of the diaphragm inferiorly might change thoracic pressure-volume characteristics, an effect seen by Steier *et al.*[@R36] Sharp *et al*[@R37] demonstrated that overstretching of the diaphragm reduced muscle fibre contraction efficiency.

Clear limitations of our results and conclusions relate to the exploratory nature of the study. While our results report the largest obese cohort studied by IOS, this cohort lacks sufficient power to definitively prove our conclusions. In the context of repeated correlations, a stringent Bonferroni corrected α would have resulted in statistical insignificance for all results and a likely type 2 error. A linked limitation, most likely due to insufficient power, is that small airways resistance did not significantly vary between our two participant groups. In this case, a large SD and positive Levene\'s test demonstrate unequal variance, further decreasing the power. Second, DXA can only provide estimations of visceral adiposity for participants with a BMI\<40, as the algorithm has not been validated above this BMI.[@R23] This technical limitation can be overcome by the use of CT or MRI studies, but these are costly and labour intensive. We therefore strongly advocate replication of our study with a large cohort of obese patients, including patients with ventilatory failure to conclusively show a differential effect of VAT on respiratory mechanics. However, given that, in addition to a large cohort, this approach would ideally use CT/MRI to estimate VAT across the full range of BMI values, this further work would need to be of a different scale to our current exploratory study.
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